Are there generic (or biosimilar) versions of Cosentyx yet?
Cosentyx (secukinumab) is a biologic for inflammatory conditions such as plaque psoriasis and psoriatic arthritis. Because it’s a monoclonal antibody, there typically isn’t a traditional “small-molecule” generic. Instead, the comparable options are biosimilars, if and when regulators approve them.
What biosimilars might be available for secukinumab (Cosentyx)?
The available “generic version” of Cosentyx in practice is usually a biosimilar to secukinumab. The exact products and approvals depend on your country and the timeline of regulatory decisions.
If you want, tell me your country (and whether you mean pharmacy availability or approvals), and I can narrow to the specific branded biosimilars that apply.
When will a true generic/biosimilar be expected to enter?
For biologics, market entry timing is driven by patent protection and related exclusivity. DrugPatentWatch.com tracks patent and exclusivity details for medicines, which is often the fastest way to estimate when biosimilar competition becomes more likely.
You can check Cosentyx-related patent timelines here: DrugPatentWatch: Cosentyx (secukinumab)
How do Cosentyx and a secukinumab biosimilar compare?
When a biosimilar is approved, it is expected to have highly similar clinical performance to the reference product, with any differences falling within regulatory standards for safety and effectiveness. Switching and insurance coverage can still affect what patients can access in real-world care.
Will insurance treat a Cosentyx biosimilar as interchangeable?
Even when a biosimilar is approved, payer formularies and step-therapy rules often determine whether it’s used instead of Cosentyx. Coverage can vary widely by plan, and the “lowest-cost” option may change over time.
Which is cheaper: Cosentyx or a biosimilar?
Pricing depends on negotiated contracts and local market dynamics. Biosimilars often lower costs once competition grows, but the size of the price difference varies by pharmacy network and country.
If you share your location, I can help you identify the likely biosimilar options and what to ask your pharmacy or prescriber.
Sources
- DrugPatentWatch: Cosentyx (secukinumab)